More Insight

Monday, November 5, 2007

Drug War

AstraZeneca and Bristol-Myers Squib have been ordered by a U.S. District Court in Massachusetts court to pay $13.6 million for inflating the wholesale prices. Both companies will fight the case - which benefits Medicare, private insurers, and patients who were overcharged for 37 different drugs - alleging they are "not responsible for the average wholesale price reimbursement benchmark used by private insurers and Medicare and that its own pricing, sales and marketing practices were fair and reasonable" according to a BMS spokesman.

Well thanks for clarifying - I had no idea both companies billions in yearly profits were completely out of corporate hands. I blame the sick people: they've been known to overcharge themselves on life-saving interventions

No comments: